Enlighten
Research publications by members of the University of Glasgow
home > services > Enlighten

Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study

Smith, F., Lee, A.J., Hau, C.M., Rumley, A., Lowe, G.D.O., and Fowkes, F.G.R. (2000) Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study. Blood Coagulation and Fibrinolysis, 11 (1). pp. 43-50. ISSN 0957-5235

Full text not currently available from Enlighten.

Publisher's URL: http://www.bloodcoagulation.com/pt/re/bcf/home.htm

Abstract

The role of fibrinogen and other haemostatic factors in prediction of peripheral arterial disease (PAD) has not been established. We examined the associations of plasma fibrinogen, von Willebrand Factor (vWF), tissue plasminogen activator (t- PA) antigen, fibrin D-dimer, and factor VII with the development and clinical progression of PAD. In the Edinburgh Artery Study, 1592 men and women, aged between 55 and 74 years, were followed prospectively over 5 years to detect the onset of PAD, and the deterioration of established PAD. At baseline, 418 individuals had evidence of PAD and 60 (14.4%) subsequently deteriorated. 1080 subjects had no baseline disease, but 59 (5.5%) developed PAD during follow-up. Median levels of fibrinogen and vWF were higher in the group developing disease compared with the group which did not (2.78 g/l versus 2.57 g/l, P less than or equal to 0.01; 116 IU/dl versus 104 IU/dl, P less than or equal to 0.05; respectively). After adjusting for age and sex, fibrinogen (P less than or equal to 0.01) and vWF (P less than or equal to 0.05) were significantly associated with the risk of developing PAD. The association between fibrinogen and development of disease remained after adjusting for cardiovascular risk factors and baseline ischaemic heart disease (relative risk, 1.35, 95% confidence interval 1.05, 1.73; P less than or equal to 0.05). None of the haemostatic factors were significantly associated with progression of PAD. In conclusion, plasma fibrinogen levels are related to the future onset of PAD, providing further evidence of a possible role of elevated fibrinogen in the development of atherosclerotic disease.

Item Type:Article
Status:Published
Refereed:Yes
Glasgow Author(s):Fowkes, Prof Francis and Rumley, Dr Ann and Lowe, Prof Gordon
Authors: Smith, F., Lee, A.J., Hau, C.M., Rumley, A., Lowe, G.D.O., and Fowkes, F.G.R.
Subjects:R Medicine > RC Internal medicine
College/School:College of Medical Veterinary and Life Sciences
College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences > Cardiovascular Science
Journal Name:Blood Coagulation and Fibrinolysis
Publisher:Oxford University Press
ISSN:0957-5235
ISSN (Online):10.1093/qjmed/95.4.199

University Staff: Request a correction | Enlighten Editors: Update this record